Company overview
- Sector
- Pharmaceuticals, Healthcare & Life Sciences
- Sub-sector
- Pharmaceuticals
- Mandate (derived)
- Multi-Function / Full-Stack GCC
- Parent headquarters
- New York, New York, United States
- Parent revenue (USD)
- $62,600,000,000
- Parent headcount
- 36,057
- India headcount
- 500-1,000
GCC locations
- Chennai
- Mumbai
GCC notes
Supply chain tech, regulatory data and drug development digital tools
Department mix
Global department counts, used as a proxy for the India mandate. These are not India team counts.
Technology stack
- .NET
- 10x Genomics
- 24-7 Media
- A Small Orange
- ABB Distributed Control Systems (DCS)
- AC500 PLC
- ACCELQ
- ACL
- ADP
- AI
- AMP
- ANGEL LMS
- API Gateway
- AVEVA InTouch HMI
- AVEVA PDMS
Public leadership
Debjit Biswas
Vice President, Data Sciences and Analytics
Public leadership listed in the dataset; the role is not necessarily the India GCC head.
Key roles
Data Scientists; Software Engineers (Pharma Supply Chain); Business Analysts; AI/ML Engineers; Regulatory Technology Analysts
Research overview
Pfizer Inc. is a US pharmaceutical and vaccines company founded in 1849, headquartered in New York City, listed on the NYSE and led by Chairman & CEO Dr. Albert Bourla. It researches, develops and distributes medicines and vaccines across oncology, vaccines, internal medicine and inflammation & immunology.
- India launch
- 2022
- Maturity
- Multi-Function / Full-Stack GCC
Pfizer's India footprint spans a 250+ person Chennai R&D/manufacturing-technology center opened in 2022 and a Mumbai-based global capability centre (Analytics Gateway) launched in 2024 covering data science, AI and commercial analytics for 140+ markets - combining scientific R&D and commercial analytics/GCC work.
Location rationale
For the Chennai center, Pfizer and IIT Madras Research Park leadership cited proximity to IIT Madras for academia-industry collaboration and access to India's research talent pool. For the Mumbai Analytics Gateway, Pfizer India's Country President cited access to India's skilled data-science and analytics talent.
Timeline
- 2022-05-04
Pfizer inaugurated its Global Drug Development Centre at the IIT Madras Research Park in Chennai - its first such center in Asia, part of a 12-center global network, ~$20 million investment.
- 2023-04-03
Meenakshi Nevatia took charge as Managing Director / Country President of Pfizer India.
- 2024-09-18
Pfizer launched the 'Analytics Gateway' in Mumbai - a global capability centre for data science, AI and commercial analytics serving 140+ markets outside the US.
Real estate
chennai: [object Object]; mumbai: null
News and developments
Pfizer Inc. Sets Up Analytics Gateway in India, a Capability Centre Driving Growth through Best-in-Class Analytics, Top Talent, and Innovation
Pfizer launched the Analytics Gateway in Mumbai, a global capability centre for data science, AI and commercial analytics serving 140+ markets.
2024-09-18 Pfizer India press release ↗
Pfizer & Cipla announce exclusive marketing and distribution partnership for select brands in India
Partnership announcement for select brand marketing and distribution in India.
2025-12-19 Pfizer India News & Media ↗
Sources
Sources and research notes
Source: Indian GCC 2026 Master Compendium, Company Master and research records. Sector, mandate and public leadership are derived fields. Missing values are shown as not disclosed. Revenue and global headcount describe the parent company, not the India centre.